TrialThe Journal of antimicrobial chemotherapy2022

Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305.

Todd T Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.